Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Wall Street Analysts Think Promis Neurosciences (PMN) Could Surge 231.78%: Read This Before Placing a Bet
Wall Street Analysts Think Promis Neurosciences (PMN) Could Surge 231.78%: Read This Before Placing a Bet

Promis Neurosciences (PMN) closed the last trading session at $10.7, gaining 1.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

GeoVax Labs (GOVX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
GeoVax Labs (GOVX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Shares of GeoVax Labs Inc. (GOVX) have been struggling lately and have lost 34.1% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that

BHP Advances Lower-Carbon Conveyor Solutions With BOTON Partnership
BHP Advances Lower-Carbon Conveyor Solutions With BOTON Partnership

BHP Group Limited BHP announced that it signed a Global Framework Agreement with Wuxi BOTON Technology Co., Ltd. to boost their partnership to develop greener and more innovative conveyor

DAVE Stock Rises 49% in 6 Months: Is There More Upside Ahead?
DAVE Stock Rises 49% in 6 Months: Is There More Upside Ahead?

Dave Inc. DAVE stock delivered exceptional growth over the past six months. It gained 49.4%, outperforming the industry’s 8.9% dip and the Zacks S&P 500 composite's 7.6% rally.

Over the past six

GSK's Momelotinib Gets Orphan Tag for Rare Hemato-Inflammatory Disorder
GSK's Momelotinib Gets Orphan Tag for Rare Hemato-Inflammatory Disorder

GSK plc GSK announced that the FDA and European Medicines Agency (EMA) have granted Orphan Drug Designation (ODD) to its JAK inhibitor, momelotinib, for treating VEXAS syndrome.

ODD is a special

Is Western Digital's Free Cash Flow Supporting Long-Term Growth?
Is Western Digital's Free Cash Flow Supporting Long-Term Growth?

Western Digital Corporation’s WDC strong free cash flow generation is emerging as a key pillar supporting its long-term growth strategy while reinforcing shareholder returns and financial stability

Chewy's Autoship Business Continues to Drive Recurring Revenue Growth
Chewy's Autoship Business Continues to Drive Recurring Revenue Growth

Chewy, Inc.’s CHWY Autoship business remained a key contributor to growth in the first quarter of fiscal 2026. Autoship customer sales increased more than 10% year over year to $2.83 billion and

Tractor Supply Bets on Rural Lifestyle Demand: Smart Move?
Tractor Supply Bets on Rural Lifestyle Demand: Smart Move?

Tractor Supply Company TSCO continues to lean into the growing rural lifestyle trend, positioning itself as a key destination for farm, ranch, pet and outdoor living needs. Despite a cautious

Do Options Traders Know Something About PDD Holdings Stock We Don't?
Do Options Traders Know Something About PDD Holdings Stock We Don't?

Investors in PDD Holdings Inc. PDD need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $55.00 Call had some of the highest implied

Here's Why Steel Dynamics (STLD) is a Strong Momentum Stock
Here's Why Steel Dynamics (STLD) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why TJX (TJX) is a Strong Momentum Stock
Here's Why TJX (TJX) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Why Jones Lang LaSalle (JLL) is a Top Momentum Stock for the Long-Term
Why Jones Lang LaSalle (JLL) is a Top Momentum Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Valero Energy (VLO) is a Top-Ranked Momentum Stock: Should You Buy?
Valero Energy (VLO) is a Top-Ranked Momentum Stock: Should You Buy?

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why PBF Energy (PBF) is a Top Momentum Stock for the Long-Term
Why PBF Energy (PBF) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why Jefferies (JEF) is a Top Momentum Stock for the Long-Term
Why Jefferies (JEF) is a Top Momentum Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Why Casey's General Stores (CASY) is a Top Momentum Stock for the Long-Term
Why Casey's General Stores (CASY) is a Top Momentum Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Here's Why Equifax (EFX) is a Strong Momentum Stock
Here's Why Equifax (EFX) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Why FactSet Research (FDS) is a Top Momentum Stock for the Long-Term
Why FactSet Research (FDS) is a Top Momentum Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Here's Why Anheuser-Busch Inbev (BUD) is a Strong Momentum Stock
Here's Why Anheuser-Busch Inbev (BUD) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Here's Why Bandwidth (BAND) is a Strong Momentum Stock
Here's Why Bandwidth (BAND) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Waste Management Infrastructure Strengthens WM Amid Weak Liquidity
Waste Management Infrastructure Strengthens WM Amid Weak Liquidity

WM WM is benefiting from continued demand for its robust infrastructure and extensive asset network, including landfills, recycling facilities and waste-to-energy plants. The company’s strategic

5 Low Price-to-Book Stocks That Are Worth Buying in June
5 Low Price-to-Book Stocks That Are Worth Buying in June

When assessing a company’s valuation, investors typically rely on metrics such as the price-to-earnings (P/E) ratio and the price-to-sales (P/S) ratio. The P/E ratio measures how much investors are

Venture Global & Atlantic-SEE Double LNG Supply to GreecePhoto, wide shot, wide-angle lens,  Gas company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/01083d82-021d-4573-8c40-0e836a0771d6.png
Venture Global & Atlantic-SEE Double LNG Supply to Greece

Venture Global, Inc. VG and Greece-based Atlantic-SEE LNG Trade have strengthened their strategic partnership by expanding the existing long-term liquified natural gas ("LNG") Sales and Purchase

IMRX Begins Dosing in Phase III Pancreatic Cancer Study, Stock Up
IMRX Begins Dosing in Phase III Pancreatic Cancer Study, Stock Up

Shares of Immuneering Corporation IMRX were up 5.1% yesterday after the company announced the dosing of the first patient in a pivotal phase III study evaluating its lead product candidate

Why MasTec (MTZ) is a Top Growth Stock for the Long-Term
Why MasTec (MTZ) is a Top Growth Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different